- HealthTech
- Wednesday, 24 Jun 2020
Revolutionary Live Cell Encapsulation Altering the Future of Medical technology
Cell encapsulation is probably the solution for most of the chronic disease, which had not yet been attended by most of the pharmaceutical therapeutics. The cellular system might possibly enable seamless treatment in upcoming years as certain clinical trials are evaluating the use of encapsulated cells for several human diseases.
Cell encapsulation includes immobilization of xenogeneic cells within a semipermeable, yet in immunoprotective membrane. Thus, it offers therapeutics’ without requiring immunosuppression. Potentials of the therapeutics have been taken from two key instances; islet cell delivery for diabetes and MSCs-based therapies.
“I think diabetes is where this type of technology really lends itself to the application. The key is to develop the right type of cell line to treat Type 1 and insulin-dependent Type 2 diabetes. There are several cell lines being explored by PharmaCyte simultaneously to do this,” said David A. Judd, a cellular biologist and a member of PharmaCyte’s Medical and Scientific Advisory Board in a press release. PharmaCyte Biotech, a global biotechnology company that has been in the market for a while now and is already developing therapies for both diabetes and cancer using cell-based cell encapsulation technology (Cell-in-a-Box®).
The technology further is the representation of a process with an ample amount of applications. These when combined together offers an ability of preserving cells within the encapsulation matrix. The applications include:
- Tissue fabrication and 3D printing of cell
- Enhancing therapeutic cell delivery
- Creating in 3D cell cultures for pharmacological screening and testing its toxicity if any
- Upstream bioprocessing of cells
The global market for live cell encapsulation has a highly competitive landscape with large number of players developing cell-based therapies. Despite the market having a huge scope, there are certain limitations impeding it growth, like lack of technical skills, limited availability of high quality raw material and the significant adoption of alternative therapies as per the report by The Insight partners.
Related Industry Updates
Asia Pacific Tissue Engineering Market Insights, Deep Analysis of Key Vendor in the Industry 2020 to 2027
Apr 01, 2021
Chronic Disease Management Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2027 By Allscripts , ScienceSoft USA Corporation , Siemens Healthcare Private Limited , Koninklijke Philips N.V ,
Apr 08, 2021
Impact of Corona on Europe Personal Care Wipes Market during 2020-2027
Jul 17, 2020
Latest Report on Europe Rare Neurological Disease Treatment Market 2020-2027| Types, Applications, Regional Analysis and Key Companies Bayer AG, GlaxoSmithKline plc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi
Dec 07, 2020
Patient-controlled Analgesic Infusion Pumps Market: Supply-Demand, Industry Research and End User Analysis, Outlook 2027
Feb 17, 2021
North America Surgical Navigation Systems Market is expected to reach US$ 1,048.26 million by 2030
Oct 11, 2023
Epigenetics Market is expected to reach US$ 3092.48 million by 2028
Feb 09, 2023